Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns

Journal of Clinical Pathology

Volumn 52, Issue 2, 1999, Pages 124-128

  Wong, R C W ^b   Silvestrini, R A ^c   Savige, J A ^a   Fulcher, D A ^c   Benson, E M ^c  

^a AUSTIN HEALTH   (Australia)

^b SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^c NONE

Author keywords

Atypical ANCA; Classical ANCA; Cytoplasmic ANCA

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LABORATORY TEST; NEUTROPHIL; PRIORITY JOURNAL; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0000194835     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.2.124     Document Type: Article

References (22)

1. 1 Roberts DE. Antineutrophil cytoplasmic autoantibodies. Clin Lab Med 1992;12:85-98.
2. 2 Rasmussen N, Wiik A. Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS 1989; 97(suppl 6): 16-20.
3. 3 Rasmussen N, Wiik A. Autoimmunity in Wegener's granulomatosis. Immunobiology, autoimmunity and transplantation in otorhinolaryngology. In: Veldman JE, McCabe BF, Houzing EH, et al, eds. Proceedings of the 1st International Conference, Utrecht, The Netherlands, 1984. Amsterdam: Kugler Publications, 1985:231-6.
4. 4 Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
5. 5 Rao JK, Allen NB, Feussner JR, et al. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995;346:926-31.
6. 6 van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
7. 7 Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577-87.
8. 8 Jennings JG, Chang L, Savige JA. Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 1994;95:251-6.
9. 9 Baslund B, Segelmark M, Wiik A, et al. Screening for antineutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol 1995;99:486-92.
10. 10 Lock RJ. ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994;47:4-8.
11. 11 Zola H, Roberts-Thomson P, McEvoy R. Autoimmune serology. In: Zola H, Roberts-Thomson P, McEvoy R, eds. Diagnostic immunopathology: laboratory practice and clinical application. Cambridge: Cambridge University Press, 1995: 62-112.
12. 12 Nassberger L. Distribution of antineutrophil cytoplasmic autoantibodies in SLE patients with and without renal involvement. Am J Nephrol 1996;16:548-9.
13. 13 Papo M, Quer JC, Pastor RM, et al. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 1996;91:1512-15.
14. 14 Niles JL. Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med 1996;47:303-13.
15. 15 Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97(suppl 6):12-13.
16. 16 Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
17. 17 Bini P, Gabay JE, Teitel A, et al. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992;149:1409-15.
18. 18 Aitola P, Miettinen A, Mattila A, et al. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J Clin Pathol 1995;48:645-7.
19. 19 Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
20. 20 Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing glomerulonephritis. N Engl J Med 1988;318:1651-7.
21. 21 Zhao MH, Jones SJ, Lockwood CM. Bactericidal/ permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995;99:49-56.
22. 22 Savige JA, Paspaliaris B, Silvestrini R, et al. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 1998;51:569-75.